ACGT announces CEO and President John Walter, succeeding Barbara Netter who will remain on Board as Honorary Chairman. Walter is the former CEO of the Leukemia and Lymphoma Society where he dramatically increased revenues and expanded research to focus on partnerships with biotech and academia. Read more.
Advancing molecular therapies for cancer
ACGT Newsletter
Donate to ACGT
